Phathom Pharmaceuticals, Inc. (PHAT) vs Replimune Group, Inc. (REPL)
Detailed comparison between Phathom Pharmaceuticals, Inc., Replimune Group, Inc..Total Return (%)
Phathom Pharmaceuticals, Inc. (PHAT)Replimune Group, Inc. (REPL)
Which stock do you think will perform better?
Phathom Pharmaceuticals, Inc.
PHAT
Replimune Group, Inc.
REPL
| Metric | Phathom Pharmaceuticals, Inc. (PHAT) | Replimune Group, Inc. (REPL) |
|---|---|---|
| Current Price | $5.34 | $13.61 |
| Change | -0.33 (-5.82%) | -0.37 (-2.65%) |
| Market Cap | $0.37B | $1.05B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.33 | -5.06 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $19.71 | $17.00 |
| 52-Week Low | $5.21 | $4.92 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.74 | $-3.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| PHAT | -18.60% | -18.60% | -46.12% | -85.21% | -78.29% | -78.29% |
| REPL | -0.58% | -0.58% | 58.07% | -9.93% | -10.22% | -10.22% |